Carbon nanotubes give cancer drugs a boost
Both graphene oxide and single-walled carbon nanotubes were found to enhance cancer-cell death in lung-cancer cells when combined with the Paclitaxel, indicating a synergistic effect that has been identified as reactive-oxygen species dependent.
Combination therapies, where more than one therapeutic agent is used to treat a cancer, were first developed to tackle heterogeneity in tumours – that is the presence of more than one type of cell. Typically this involves combinations of different drugs, but the use of carbon-based nanomaterials instead could lower the side effects experienced by patients, while still offering enhanced treatment effects.
Original publication
Organizations
Other news from the department science
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.